» Authors » R C Rosen

R C Rosen

Explore the profile of R C Rosen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 137
Citations 5422
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Wolf E, Bovin M, Green J, Mitchell K, Stoop T, Barretto K, et al.
Psychol Med . 2016 Apr; 46(10):2215-26. PMID: 27087657
Background: Post-traumatic stress disorder (PTSD) is associated with elevated risk for metabolic syndrome (MetS). However, the direction of this association is not yet established, as most prior studies employed cross-sectional...
2.
Hou C, Zang Y, Rosen R, Cai M, Li Y, Jia F, et al.
Compr Psychiatry . 2016 Jan; 65:116-21. PMID: 26773999
Purpose: Sexual dysfunction in schizophrenia patients is common. In China, maintenance treatment for clinically stable patients with schizophrenia is usually provided by primary care physicians. Illness- or treatment-related sexual dysfunction...
3.
Egan K, Miner M, Suh M, McVary K, Ni X, Roehrborn C, et al.
Andrology . 2015 Oct; 3(6):1165-72. PMID: 26452447
Little is known about how total testosterone and estradiol-17β influence lower urinary tract symptoms (LUTS) in men with benign prostatic hypertrophy (BPH). We analyzed data from a subset of men...
4.
Egan K, Suh M, Rosen R, Burnett A, Ni X, Wong D, et al.
Int J Clin Pract . 2015 Jul; 69(11):1316-25. PMID: 26215544
Objective: The objective of this study was to investigate rural/urban and socio-demographic disparities in lower urinary tract symptoms and benign prostatic hyperplasia (LUTS/BPH) in a nationally representative population of men....
5.
Constantine G, Graham S, Portman D, Rosen R, Kingsberg S
Climacteric . 2014 Sep; 18(2):226-32. PMID: 25252699
Background: Ospemifene is a non-estrogen, tissue selective estrogen receptor agonist/antagonist, or selective estrogen receptor modulator, recently approved for the treatment of dyspareunia, a symptom of vulvar and vaginal atrophy (VVA),...
6.
Rosen R, Yang M, Hall S, Roehrborn C
Urology . 2014 Mar; 83(5):1041-50. PMID: 24674118
Objective: To investigate the natural history of urologic symptom progression and remission by means of cluster analysis in a large, well-characterized cohort of men and women. Methods: Cluster analysis was...
7.
Seftel A, Rosen R, Hayes R, Althof S, Goldfisher E, Shen W, et al.
Int J Clin Pract . 2014 Mar; 68(7):841-9. PMID: 24666765
Introduction: For men with erectile dysfunction (ED), the expectation of difficulty and level of confidence in achieving and maintaining an erection have an impact on sexual performance. Objective And Methods:...
8.
Hayes R, Seftel A, Rosen R, Althof S, Shen W, Shih T, et al.
Int J Impot Res . 2013 Dec; 26(3):105-11. PMID: 24335748
The objective of this study was to perform psychometric testing of two new patient-reported outcome instruments (PROs), the Confidence in Performing Sexual Intercourse Questionnaire (CPSIQ) and the Difficulty in Performing...
9.
Sontag A, Ni X, Althof S, Rosen R
Int J Impot Res . 2013 Jul; 26(1):7-12. PMID: 23864107
Sexual self-confidence has been shown to be associated with erectile function (EF) in men receiving PDE-5 inhibitor therapy; however, few studies have investigated the pathways (for example, sexual satisfaction, communication,...
10.
Alexander M, Rosen R, Steinberg S, Symonds T, Haughie S, Hultling C
Spinal Cord . 2010 Aug; 49(2):273-9. PMID: 20733587
Study Design: Double-blind, placebo-controlled, flexible-dose study. Objective: To evaluate the efficacy, safety and tolerability of oral sildenafil in women with female sexual arousal disorder as a result of SCI (paraplegia/tetraplegia)....